CoverageForm 410-K10-Q8-K13D13G13F

LCTC · Lifeloc Technologies, Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · LCTC

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$9.03M$8.54M$9.33M$8.48M$7.05M$6.36M
Cost of Revenue$5.38M$5.09M$5.29M$5.41M$3.99M$4.18M
Gross Profit$3.64M$3.45M$4.04M$3.07M$3.06M$2.18M
R&D$2.15M$2.24M$1.84M$1.39M$1.21M$1.01M
SG&A$1.39M$1.25M$1.17M$1.22M$1.11M$1.25M
Total Operating Expenses$4.87M$4.85M$4.23M$3.73M$3.33M$3.34M
D&A$443.5K$298.3K$264.8K$632.4K$254.8K$364.3K
Operating Income($1.23M)($1.41M)($191.1K)($650.3K)($268.9K)($1.16M)
Interest Expense$119.2K$40.1K$41.6K$43.1K$51.3K$56.1K
Income Tax$1.16M($352.5K)($368.3K)($117.0K)($56.3K)($275.4K)
Net Income($2.47M)($1.05M)$205.6K($455.8K)$676.0K($921.9K)
EPS - Basic($0.90)($0.41)$0.08($0.19)$0.28($0.38)
EPS - Diluted($0.90)($0.41)$0.08($0.19)$0.27($0.38)

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$746.0K$1.24M$1.77M$2.35M$2.57M$2.20M
Accounts Receivable$772.4K$732.5K$812.1K$627.9K$562.1K$523.6K
Inventory$2.63M$3.00M$3.02M$2.73M$2.67M$2.50M
Accounts Payable$301.6K$251.6K$402.2K$414.0K$446.0K$333.9K
Current Assets$4.27M$5.09M$5.71M$5.88M$5.86M$5.52M
Total Assets$6.69M$8.72M$8.69M$8.52M$8.95M$8.54M
Current Liabilities$836.9K$743.6K$1.15M$1.14M$1.08M$1.35M
Long-term Debt$1.06M$1.12M$1.17M$1.22M$1.27M$1.28M
Total Liabilities$2.58M$2.50M$2.33M$2.36M$2.36M$2.64M
Stockholders' Equity$4.10M$6.23M$6.36M$6.16M$6.59M$5.90M
Retained Earnings($1.83M)$639.9K$1.69M$1.49M$1.94M$1.27M

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow($499.3K)($1.33M)($525.7K)$54.3K$182.9K($1.36M)
Investing Cash Flow($354.4K)($689.4K)($8.2K)($222.6K)($268.5K)($46.3K)
Financing Cash Flow$356.0K$1.49M($52.2K)($50.7K)$462.1K$419.1K
CapEx$462.8K$539.7K$6.8K$213.2K$265.9K$27.5K
Free Cash Flow($962.1K)($1.87M)($532.6K)($158.9K)($82.9K)($1.39M)

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin40.3%40.4%43.3%36.3%43.4%34.3%
Operating margin-13.6%-16.5%-2.0%-7.7%-3.8%-18.2%
EBITDA margin-8.7%-13.0%0.8%-0.2%-0.2%-12.4%
Net margin-27.4%-12.3%2.2%-5.4%9.6%-14.5%
Free cash flow margin-10.7%-21.9%-5.7%-1.9%-1.2%-21.9%
FCF / Net income0.391.77-2.590.35-0.121.51
R&D / Revenue23.8%26.3%19.7%16.3%17.2%15.8%
SG&A / Revenue15.4%14.7%12.5%14.3%15.8%19.7%
Effective tax rate-----9.1%-
Return on assets-36.9%-12.1%2.4%-5.4%7.6%-10.8%
Return on equity-60.2%-16.9%3.2%-7.4%10.3%-15.6%
Return on invested capital-18.8%-15.1%-2.0%-7.0%-3.4%-12.7%
Liquidity
Current ratio5.106.854.975.175.414.07
Quick ratio1.952.822.342.772.952.23
Cash ratio0.891.671.542.072.381.62
Leverage
Debt / Equity0.260.180.180.200.190.22
Debt / Assets0.160.130.130.140.140.15
Debt / EBITDA--15.88---
Interest coverage-10.3x-35.1x-4.6x-15.1x-5.2x-20.6x
Equity multiplier1.631.401.371.381.361.45
Liabilities / Assets0.390.290.270.280.260.31
Efficiency
Asset turnover1.350.981.071.000.790.74
Inventory turnover2.041.701.751.981.501.67
Days sales outstanding31d31d32d27d29d30d
Days inventory outstanding179d215d209d184d244d218d
Days payable outstanding20d18d28d28d41d29d
Cash conversion cycle189d228d213d184d232d219d
Valuation
P / E--27.6x-16.9x-
P / B1.6x1.1x0.9x0.9x1.7x0.9x
P / S0.7x0.8x0.6x0.6x1.6x0.8x
EV / EBITDA--65.5x---
Growth
Revenue growth (YoY)5.7%-8.5%10.0%20.2%11.0%-27.4%
Revenue CAGR (3y)2.1%6.6%13.6%-1.0%-4.1%-7.3%
Revenue CAGR (5y)7.3%-0.5%3.1%1.2%-3.4%-6.4%
Gross profit growth (YoY)5.7%-14.7%31.4%0.5%40.3%-44.6%
Operating income growth (YoY)12.7%-636.8%70.6%-141.8%76.7%-
Net income growth (YoY)-134.6%-----
EPS growth (YoY)-119.5%-----
EPS CAGR (3y)----44.2%-
EPS CAGR (5y)---2.3%-9.7%-
FCF growth (YoY)48.5%-250.7%-235.2%-91.6%94.0%-
FCF CAGR (5y)------
Book value growth (YoY)-34.1%-2.1%3.3%-6.7%11.7%-13.1%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2024-12-31.

Product / service

$17.01M total
Product Sales Subtotal$8.47M · 49.8%
Product Sales And Supplies$7.74M · 45.5%
Training Certification And Data Recording$651.4K · 3.8%
Service Plans And Equipment Rental$81.8K · 0.5%
Royalties$34.4K · 0.2%
Rental Income$32.8K · 0.2%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

1.58
Grey zone

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

3/9
Weak
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Laboratory Analytical Instruments

CompanyRevenue (last FY)Net marginROE
AVTR$6.55B-8.1%-9.5%
QTRX$138.90M-77.1%-36.2%
ILMN$4.34B19.6%31.2%
A---
CTKB$201.49M-33.0%-19.5%

Comparing Lifeloc Technologies against the 5 most active filers in the same SIC group.